Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: EN Paris
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

BIM:FP

102.2000 EUR 0.3000 0.29%

As of 09:54:02 ET on 05/26/2015.

Snapshot for BioMerieux (BIM)

Open: 102.1500 Day's Range: 101.4500 - 102.9000 Volume: 14,847
Previous Close: 101.9000 52wk Range: 76.3200 - 104.0000 1-Yr Rtn: +28.81%

Stock Chart for BIM

No chart data available.
  • BIM:FP 102.2000
  • 1D
  • 1M
  • 1Y
101.9000
Interactive BIM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BIM

Current P/E Ratio (ttm) 29.8977
Estimated P/E(12/2015) 24.6564
Relative P/E vs. CAC 1.1368
Earnings Per Share (EUR) (ttm) 3.4200
Est. EPS (EUR) (12/2015) 4.1470
Est. PEG Ratio 1.9884
Market Cap (M EUR) 4,034.14
Shares Outstanding (M) 39.45
30 Day Average Volume 31,442
Price/Book (mrq) 2.9259
Price/Sale (ttm) 2.3787
Dividend Indicated Gross Yield 0.98%
Cash Dividend (EUR) 1.0000
Dividend Ex-Date 06/05/2015
5 Year Dividend Growth 4.30%
Next Earnings Announcement 09/02/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BIM

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for BIM

BioMerieux designs, develops, manufactures, and markets systems in the field of in vitro diagnostics for medical and industrial applications. The Company is specialized in the diagnosis of infectious diseases and pathologies. BioMerieux is also active in the analysis of food, pharmaceuticals and environmental samples to determine their microbiological quality.

Jean-Luc BelingardChairmanAlexandre MerieuxChief Executive Officer
Mark MillerChief Medical OfficerFrancois LacosteVP:Immunoassay
More Company Profile & Key Executives for BIM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil